blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2352834

EP2352834 - VECTOR COMPRISING MULTIPLE HOMOLOGOUS NUCLEOTIDE SEQUENCES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.10.2017
Database last updated on 02.11.2024
FormerThe patent has been granted
Status updated on  18.11.2016
FormerGrant of patent is intended
Status updated on  07.11.2016
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
Bavarian Nordic A/S
Hejreskovvej 10 A
3490 Kvistgaard / DK
[2011/32]
Inventor(s)01 / STEIGERWALD, Robin
Ickstattstrasse 12
80469 München / DE
 [2011/32]
Representative(s)Bendiksen, Henrik, et al
Bavarian Nordic GmbH
Patent Department
Fraunhoferstraße 13
82152 Martinsried / DE
[2013/37]
Former [2013/20]Schiweck, Weinzierl & Koch
European Patent Attorneys Landsberger Straße 98
80339 München / DE
Former [2011/32]Pielken, Petra
Bavarian Nordic GmbH Fraunhoferstrasse 13
82152 Martinsried / DE
Application number, filing date09756267.220.11.2009
[2011/32]
WO2009EP08275
Priority number, dateUS20080116672P21.11.2008         Original published format: US 116672 P
[2011/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010057650
Date:27.05.2010
Language:EN
[2010/21]
Type: A1 Application with search report 
No.:EP2352834
Date:10.08.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2010 takes the place of the publication of the European patent application.
[2011/32]
Type: B1 Patent specification 
No.:EP2352834
Date:21.12.2016
Language:EN
[2016/51]
Search report(s)International search report - published on:EP27.05.2010
ClassificationIPC:C12N15/863
[2011/32]
CPC:
C12N15/86 (EP,CN,US); C12N15/64 (KR); C12N15/8636 (US);
C12N15/863 (KR); C12N7/00 (KR); C12N15/8613 (US);
C12N2710/24121 (US); C12N2710/24134 (US); C12N2710/24141 (US);
C12N2710/24143 (EP,CN,US); C12N2710/24151 (US); C12N2740/11022 (EP,CN,US);
C12N2760/14122 (EP,CN,US); C12N2799/02 (US); C12N2800/22 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/51]
Former [2011/32]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesAL04.05.2011
BA04.05.2011
RS04.05.2011
TitleGerman:VIRUS BESTEHEND AUS NUCLEOTIDESEQUENZEN KODIEREND FÜR MULTIPEL HOMOLOGEN[2016/30]
English:VECTOR COMPRISING MULTIPLE HOMOLOGOUS NUCLEOTIDE SEQUENCES[2011/32]
French:VIRUS COMPRENANT SÉQUENCES D' ACIDES NUCLÉIQUES CODANT LES MULTIPLES HOMOLOGUES[2016/50]
Former [2011/32]VEKTOR MIT MEHREREN HOMOLOGEN NUKLEOTIDSEQUENZEN
Former [2011/32]VECTEUR COMPORTANT DE MULTIPLES SÉQUENCES NUCLÉOTIDIQUES HOMOLOGUES
Entry into regional phase04.05.2011National basic fee paid 
04.05.2011Designation fee(s) paid 
04.05.2011Examination fee paid 
Examination procedure04.05.2011Amendment by applicant (claims and/or description)
04.05.2011Examination requested  [2011/32]
23.10.2013Despatch of a communication from the examining division (Time limit: M06)
29.04.2014Reply to a communication from the examining division
17.09.2014Despatch of a communication from the examining division (Time limit: M06)
19.02.2015Reply to a communication from the examining division
25.11.2015Cancellation of oral proceeding that was planned for 26.11.2015
26.11.2015Date of oral proceedings (cancelled)
11.04.2016Date of oral proceedings
19.04.2016Despatch of a communication from the examining division (Time limit: M02)
19.04.2016Minutes of oral proceedings despatched
15.06.2016Reply to a communication from the examining division
01.07.2016Communication of intention to grant the patent
07.10.2016Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
07.10.2016Fee for grant paid
07.10.2016Fee for publishing/printing paid
07.11.2016Information about intention to grant a patent
07.11.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.10.2013
Opposition(s)22.09.2017No opposition filed within time limit [2017/48]
Fees paidRenewal fee
23.11.2011Renewal fee patent year 03
13.11.2012Renewal fee patent year 04
18.11.2013Renewal fee patent year 05
10.11.2014Renewal fee patent year 06
10.11.2015Renewal fee patent year 07
10.11.2016Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.11.2009
BE21.12.2016
CY21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
MK21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
TR21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
[2020/15]
Former [2019/51]HU20.11.2009
BE21.12.2016
CY21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
MK21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2019/46]HU20.11.2009
BE21.12.2016
CY21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2019/31]HU20.11.2009
BE21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2018/33]BE21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
MC21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2018/14]BE21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SI21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2017/42]BE21.12.2016
CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
PL21.12.2016
RO21.12.2016
SE21.12.2016
SK21.12.2016
SM21.12.2016
BG21.03.2017
NO21.03.2017
GR22.03.2017
IS21.04.2017
PT21.04.2017
Former [2017/35]CZ21.12.2016
EE21.12.2016
FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
RO21.12.2016
SE21.12.2016
NO21.03.2017
GR22.03.2017
Former [2017/28]FI21.12.2016
HR21.12.2016
LT21.12.2016
LV21.12.2016
SE21.12.2016
NO21.03.2017
GR22.03.2017
Former [2017/12]LV21.12.2016
Cited inInternational search[Y]WO9012880  (APPLIED BIOTECHNOLOGY INC [US]) [Y] 1-8 * the whole document *;
 [YD]WO03097846  (BAVARIAN NORDIC AS [DK], et al) [YD] 1-8 * the whole document *;
 [YD]  - FULLER M ET AL, "Helper plasmids for production of HIV-1-derived vectors", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (20011120), vol. 12, no. 17, ISSN 1043-0342, pages 2081 - 2093, XP002287261 [YD] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1089/10430340152677421
 [YD]  - HRUBY D E ET AL, "Assembly and analysis of a functional vaccinia virus "amplicon" containing the C-repeat region from the M protein of Streptococcus pyogenes.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 15 APR 1991, (19910415), vol. 88, no. 8, ISSN 0027-8424, pages 3190 - 3194, XP002524649 [YD] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.88.8.3190
 [A]  - ZHAO SHENG ET AL, "Analysis of synonymous codon usage in 11 Human Bocavirus isolates", BIOSYSTEMS, (200806), vol. 92, no. 3, ISSN 0303-2647, pages 207 - 214, XP002575799 [A] 1-8 * abstract *

DOI:   http://dx.doi.org/10.1016/j.biosystems.2008.01.006
 [A]  - ANTONIS ET AL, "Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20070530), vol. 25, no. 25, ISSN 0264-410X, pages 4818 - 4827, XP022098626 [A] 1-8 * abstract *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2007.04.002
ExaminationUS6410298
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.